TRIAMTERENE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 5 adverse event reports in the FDA FAERS database where TRIAMTERENE was used for Psoriasis.
Most Reported Side Effects for TRIAMTERENE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Coma | 60 | 17.3% | 0 | 59 |
| Gastrooesophageal reflux disease | 60 | 17.3% | 0 | 59 |
| Pneumonia aspiration | 60 | 17.3% | 0 | 59 |
| Somnolence | 60 | 17.3% | 0 | 59 |
| Underdose | 39 | 11.3% | 0 | 39 |
| Drug hypersensitivity | 37 | 10.7% | 0 | 4 |
| Off label use | 28 | 8.1% | 0 | 18 |
| Completed suicide | 25 | 7.2% | 25 | 9 |
| Drug ineffective | 23 | 6.7% | 0 | 11 |
| Lymphopenia | 22 | 6.4% | 1 | 0 |
| Product use in unapproved indication | 19 | 5.5% | 1 | 1 |
| Incorrect route of product administration | 18 | 5.2% | 0 | 18 |
| Pain in extremity | 18 | 5.2% | 0 | 3 |
| Renal failure | 18 | 5.2% | 1 | 7 |
| Thrombocytopenia | 17 | 4.9% | 1 | 0 |
Other Indications for TRIAMTERENE
Product used for unknown indication (172)
Hypertension (49)
Ewing's sarcoma (11)
Blood pressure measurement (6)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)